As the ctDNA cancer monitoring market becomes increasingly competitive, established panels continue to maintain their foothold amidst a surge of new entrants. Purdie Pascoe is conducting an ongoing syndicated study exploring the US ctDNA Cancer Monitoring Landscape. Waves 1 through 3 are available for immediate purchase, with Wave 4 launching soon.

Stephen Potts, Director at Purdie Pascoe, was recently interviewed by Rohit Sahgal, Chief Editor and AI Strategist at TVP Singapore, for the first episode of the 6th season of the Voices Project Asia Podcast. They delve into a range of topics such the importance of relationships in Asia, innovation, finding a ‘killer insight’, navigating the era of ‘info-besity’, rare diseases and the growing role of AI in healthcare.

Primary market research for precision medicine and diagnostics is complex, yet essential. The landscape is shaped by rapid advancements in genomic and proteomic sciences, the increased complexity of treatment algorithm and the need for early detection and personalised treatment plans. These factors create a dynamic environment where understanding market trends, customer needs and the competitive landscape is crucial for success.

As we navigate through the busy conference season, the industry is buzzing with innovation, networking, and knowledge sharing. Conferences are pivotal events that drive advancements, offering a unique platform for professionals to stay ahead of the curve. However, the true value of these events lies in the insights they generate.

When visiting a sensitive, emotive topic as a means to creating or refining a communications strategy, how can you optimise the true value of the voice of your customer? In this article, Sabera Hyderally and Hazel Haskayne showcase the true value of the Delphi Method and how it can be used in market research as a powerful tool for reaching consensus.

We are delighted to be attending the American Society of Clinical Oncology annual conference, May 30 - June 3 2025 in Chicago. Purdie Pascoe’s experts, Marianne Fillion and Vanessa Slade will be attending the conference, and are looking forward to meeting delegates at the biggest event in Oncology across the globe.

When visiting a sensitive, emotive topic as a means to creating or refining a communications strategy, how can you optimize the true value of the voice of your customer? Watch this webcast in which Purdie Pascoe’s expert presenters, Head of MedTech, Sabera Hyderally and Director, Hazel Haskayne, show the true value of the Delphi Method.

Stephen Potts and Seb Newton recently attended the 2025 UK One-Day EPHMRA meeting in London. The focus of the event was ‘Storytelling in Market Research’ and how as market researchers, our mission is to ensure the insights we deliver tell a meaningful, powerful story to a diverse range of stakeholders. This summary delves into key themes and presentations from experts in the field.

There are over 300 million people living with a rare disease across the globe, and they need help. Purdie Pascoe is dedicated to partnering with life science companies to make timely, informed decisions, and help improve the lives of those affected by rare diseases worldwide.

Marianne Fillion provides insights about the Precision Medicine and Diagnostics market research function at Purdie Pascoe. She delves into technological advancements, the competitive oncology landscape and why market research is so important for development and implementation in this space.

Watch this webcast in which Director and Precision Medicine expert Marianne Fillion reveals how market research can unlock integral insights such as key customer trends, product adoption and patient leakage.

Tumor agnostic indications present specific challenges that must be addressed to achieve a successful launch and ensure wide access for all patients. To prepare for these complex product and indications launches, it is paramount for commercial teams to gain insights on tumor agnostic testing behaviors, including awareness, adoption, drivers and barriers.